These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29203034)

  • 1. Atypical Presentation of Herpes Simplex Virus Type 2 Infection Refractory to Treatment With Aciclovir in 2 Hematologic Patients.
    Nieto Rodríguez D; Sendagorta Cudós E; Rueda Carnero JM; Herranz Pinto P
    Actas Dermosifiliogr (Engl Ed); 2019 Jun; 110(5):393-397. PubMed ID: 29203034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current recommendations for the treatment of genital herpes.
    Leung DT; Sacks SL
    Drugs; 2000 Dec; 60(6):1329-52. PubMed ID: 11152015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy for genital herpes in immunocompromised patients: a national survey. The Herpes Simplex Advisory Panel.
    Scoular A; Barton S
    Genitourin Med; 1997 Oct; 73(5):391-3. PubMed ID: 9534751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic perianal herpes successfully treated with imiquimod.
    Lestre SI; João A; Carvalho C; Serrão VV
    An Bras Dermatol; 2011; 86(6):1185-8. PubMed ID: 22281910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical imiquimod treatment of aciclovir-resistant herpes simplex disease: case series and literature review.
    Perkins N; Nisbet M; Thomas M
    Sex Transm Infect; 2011 Jun; 87(4):292-5. PubMed ID: 21406577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudotumoral herpes genitalis in a woman living with HIV: Diagnosis and treatment challenges.
    Tomaino MV; Sanchez Costantini M; Alfaro CT
    Int J STD AIDS; 2024 Apr; 35(5):405-408. PubMed ID: 38031871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of hypertrophic herpes simplex genitalis and treatment outcomes of imiquimod: a retrospective observational study.
    Leeyaphan C; Surawan TM; Chirachanakul P; Prasertworonun N; Punyaratabandhu P; Omcharoen V; Jiamton S
    Int J Infect Dis; 2015 Apr; 33():165-70. PubMed ID: 25660091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical presentations of genital herpes simplex virus in HIV-1 and HIV-2 effectively treated by imiquimod.
    McKendry A; Narayana S; Browne R
    Int J STD AIDS; 2015 May; 26(6):441-3. PubMed ID: 24912536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
    Perry CM; Faulds D
    Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical excision for recurrent herpes simplex virus 2 (HSV-2) anogenital infection in a patient with human immunodeficiency virus (HIV).
    Arinze F; Shaver A; Raffanti S
    Infection; 2017 Oct; 45(5):705-707. PubMed ID: 28508238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
    Ormrod D; Scott LJ; Perry CM
    Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genital herpes. A guide to pharmacological therapy.
    de Ruiter A; Thin RN
    Drugs; 1994 Feb; 47(2):297-304. PubMed ID: 7512902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient.
    Chibo D; Mijch A; Doherty R; Birch C
    J Clin Virol; 2002 Aug; 25(2):165-70. PubMed ID: 12367650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of oral acyclovir and imiquimod for the treatment of hypertrophic genital herpes simplex in HIV positive patients: report of two cases.
    Barbosa Ldo N; Souto R; Furtado AL; Gripp AC; Daxbacher E
    An Bras Dermatol; 2011; 86(5):1043-5. PubMed ID: 22147057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic genital herpes simplex due to HSV 2 sensitive to maximum dose of oral aciclovir.
    Folch H; Jahr C; Giacaman P; Zuñiga P; Del Pino M
    Clin Exp Dermatol; 2023 Jan; 48(1):43-44. PubMed ID: 36631433
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-healing genital herpes mimicking donovanosis in an immunocompetent man.
    Gupta V; Khute P; Patel A; Gupta S
    Int J STD AIDS; 2016 Jan; 27(1):72-4. PubMed ID: 25614521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valaciclovir versus aciclovir for the treatment of primary genital herpes simplex: a cost analysis.
    Pinder M; Wright A
    Int J STD AIDS; 2015 Nov; 26(13):971-3. PubMed ID: 25505043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
    Wutzler P
    Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vegetative chronic genital herpes with satisfactory response to imiquimod.
    Siqueira SM; Gonçalves BB; Loss JB; Estrella RR
    An Bras Dermatol; 2019; 94(2):221-223. PubMed ID: 31090830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.